Wecome Pharmaceutical Co Ltd (300878) — Free Cash Flow Generation Index
Wecome Pharmaceutical Co Ltd (300878) has a Free Cash Flow Generation Index of 0.99x as of June 2025. Free cash flow of CN¥50.50 Million represents 1% of operating cash flow (CN¥50.89 Million). See 300878 working capital efficiency to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Wecome Pharmaceutical Co Ltd Free Cash Flow Generation Index (2013–2023)
Historical FCF Generation Index trend for Wecome Pharmaceutical Co Ltd across 10 annual periods. Explore 300878 operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for Wecome Pharmaceutical Co Ltd (2013–2023)
Year-by-year Free Cash Flow Generation Index for Wecome Pharmaceutical Co Ltd. For the full company profile including market capitalisation, see 300878 company net worth.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2023 | -1.39x | CN¥-81.00 Million | CN¥58.29 Million | CN¥139.29 Million | ▼ -99.9% |
| 2022 | -0.70x | CN¥-101.88 Million | CN¥146.57 Million | CN¥248.44 Million | ▲ +72.8% |
| 2020 | -2.56x | CN¥-109.53 Million | CN¥42.81 Million | CN¥152.34 Million | ▼ -12928.6% |
| 2019 | -0.02x | CN¥-2.21 Million | CN¥112.76 Million | CN¥114.98 Million | ▲ +96.9% |
| 2018 | -0.64x | CN¥-67.16 Million | CN¥105.57 Million | CN¥172.73 Million | ▼ -41.5% |
| 2017 | -0.45x | CN¥-13.04 Million | CN¥29.00 Million | CN¥42.04 Million | ▼ -186.3% |
| 2016 | 0.52x | CN¥52.19 Million | CN¥100.15 Million | CN¥47.97 Million | ▲ +274.5% |
| 2015 | -0.30x | CN¥-8.85 Million | CN¥29.63 Million | CN¥38.48 Million | ▼ -357.7% |
| 2014 | 0.12x | CN¥5.33 Million | CN¥46.01 Million | CN¥40.68 Million | ▼ -79.2% |
| 2013 | 0.56x | CN¥14.51 Million | CN¥25.98 Million | CN¥11.48 Million | — |